Wikipedia

National Centre for Disease Control

(Redirected from National Institute of Communicable Diseases)
This article is about the public health agency in India. For similarly named agencies, see List of national public health agencies.

The National Centre for Disease Control (previously known as the National Institute of Communicable Diseases) is an institute under the Indian Directorate General of Health Services, Ministry of Health and Family Welfare. It was established in July 1963 for research in epidemiology and control of communicable diseases and to reorganize the activities of the Malaria Institute of India. It has nine branches at Alwar, Bengaluru, Trivandrum, Calicut, Coonoor, Jagdalpur, Patna, Rajahmundry and Varanasi to advise the respective state governments on public health. The headquarters are in Sham Nath Marg, in New Delhi.

National Centre for Disease Control
Agency overview
Formed1909; 115 years ago (1909)
Preceding agencies
  • National Institute of Communicable Diseases (1963-2008)
  • Central Malaria Bureau (1909–1963)
JurisdictionIndia
HeadquartersNew Delhi
Annual budget₹2000 crores ($270 million) (2017–18)
Ministers responsible
Agency executive
  • Dr Atul Goel, DGHS
Parent agencyMinistry of Health and Family Welfare
Websitencdc.gov.in

History

edit
 
Director S.P. Ramakrishnan at the sign for the newly renamed Central Institute for Communicable Diseases (ca. 1964). Credit: Wellcome Institute

The origin of the National Centre for Disease Control can be traced to the Central Malaria Bureau, which was established at Kasauli, Himachal Pradesh, India in 1909. It was renamed the Malaria Institute of India in 1938 and in 1963 renamed the National Institute of Communicable Diseases.[1]

The reorganized Institute was established to develop a national centre for teaching and research in various disciplines of epidemiology and control of communicable diseases. The Institute was envisaged to act as a centre par excellence for providing multi disciplinary and integrated expertise in the control of communicable disease. The Institute was also entrusted the task of developing reliable rapid economic epidemiological tools which could be effectively applied in the field for the control of communicable diseases. The objectives of the Institute broadly cover three activities - training, service and operational research in the field of communicable diseases and their prevention and control in the country. The centre is under affiliation with Guru Gobind Singh Indraprastha University, Delhi.[citation needed]

The Centre for AIDS & Related Diseases was established at National Institute of Communicable Diseases as a National Reference Laboratory as per National AIDS Control Organisation guidelines in the year 2002. Prior to this it had existed as AIDS Reference Laboratory since 1985, one of the first reference centers in India, which started surveillance of HIV infection in the country.[citation needed]

On 30 July 2009, it was named the National Centre for Disease Control.[citation needed]

Divisions

edit

The National Centre for Disease Control has 15 technical centres/divisions:[citation needed]

Operations

edit

The National Centre for Disease Control has 434 officers which consists of 5 regional branches and 20 metropolitan health surveillance units.[2][3]

Activities

edit

Doctors from the centre have investigated potential outbreaks of diseases including suspected cases of pneumonic plague in Punjab in 2002,[4] SARS outbreaks in 2004,[5] meningitis outbreak in Delhi in 2005, and avian influenza in 2006, and have reviewed preparedness for coronavirus in 2019–2020.[6][7] By February 2021, the National Centre for Disease Control found a new mutated strain E484Q of SARS-CoV-2 in the state of Maharastra that was previously thought to be coming from South Africa and Brazil.[8][9]

Indian SARS-CoV-2 Genomic Consortium

edit

In view of genomic mutations found in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the National Centre for Disease Control under the Ministry of Health and Family Welfare in collaboration with Department of Biotechnology, Indian Council of Medical Research and Council of Scientific and Industrial Research launched Indian SARS-CoV-2 Genomic Consortium in 2020. It is a national level multiple laboratory network that will help in sentinel surveillance, research genomic level variation, develop diagnostics and vaccine for severe acute respiratory syndrome (SARS) related pandemic.[10][11]

The centre is the lead agency under which ten national laboratories are working:[citation needed]

Global Disease Detection

edit

In collaboration with the Centers for Disease Control and Prevention, the National Centre for Disease Control has set up the Global Disease Detection Regional Center in New Delhi, India. This will lead to long-term public health collaboration between the Government of India and the United States in many areas including establishing high quality research and surveillance on important human infectious diseases, establishing the Indian Epidemiological Intelligence System program, and developing the National Centre for Disease Control as an international nodal agency in South Asia.[citation needed]

See also

edit

References

edit
  1. ^ Singal, Manish Kumar (17 November 204). "In Focus: Shaping health experts and aiding research". Tribune India. Archived from the original on 30 August 2017. Retrieved 29 January 2020.
  2. ^ "India National Centre for Disease Control". International Association of National Public Health Institutes. Retrieved 28 January 2020.
  3. ^ Varshney, Vibha. "Fillip, more funds for disease surveillance in Union Budget 2021-22". DownToEarth. Retrieved 21 February 2021.
  4. ^ Sethi, Chitleen K. (18 February 2002). "Tests point to plague - One more death takes toll to four". Tribune India. Retrieved 29 January 2020.
  5. ^ Sunderarajan, P. (5 April 2003). "SARS scare: two scientists sent to Bhopal". The Hindu. ISSN 0971-751X. Retrieved 29 January 2020.
  6. ^ "NCDC reviews preparedness regarding coronavirus in RML hospital". Business Standard India. 27 January 2020. Retrieved 30 January 2020.
  7. ^ Sharma, Neetu Chandra (25 January 2020). "11 people under observation for coronavirus, PMO holds high-level meeting". Livemint. Retrieved 30 January 2020.
  8. ^ Madaan, Neha (20 February 2021). "Some SARS-CoV-2 variants with mutations in few samples normal: Expert". The Times of India. Retrieved 21 February 2021.
  9. ^ "Indian SARS-CoV-2 Genomics Consortium (INSACOG) Labs release initial results of Genome sequencing of mutant variant of SARS-CoV-2". Press Information Bureau. Retrieved 21 February 2021.
  10. ^ Bhattacharya, Tapas. "Indian SARS-CoV-2 Genomics Consortium (INSACOG) launched | DD News". DD News. Retrieved 21 February 2021.
  11. ^ Kulkarni, Sagar (26 December 2020). "Covid-19: Centre forms genomic surveillance consortium; task force says no change in treatment protocol". Deccan Herald. Retrieved 21 February 2021.
edit
Retrieved from "https://en.wikipedia.org/w/index.php?title=National_Centre_for_Disease_Control&oldid=1251266716"